Repligen Corporation (RGEN)
After hours:
| Previous close | 183.81 |
| Open | 179.98 |
| Bid | 178.00 x 900 |
| Ask | 201.00 x 900 |
| Day's range | 172.18 - 190.38 |
| 52-week range | 162.29 - 327.32 |
| Volume | |
| Avg. volume | 437,424 |
| Market cap | 10.493B |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | 90.33 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
Repligen (NASDAQ: RGEN) and ResMed (NYSE: RMD) are two stocks which could fit that bill with their proven track records and growing opportunities. Repligen offers a unique way to invest in the healthcare space. Operating in both the downstream and upstream processes of drug development, Repligen sells products in the areas of filtration, chromatography, process analytics, and proteins.
- Zacks
Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan
The FDA agrees to the initiation of rolling submission of Gamida's (GMDA) BLA for its lead blood cancer candidate, omidubicel. The stock rises more than 22% on in response.
- Motley Fool
These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet
If you've got the time and intestinal fortitude to deal with a stock's big ups and downs, a big potential payoff awaits. If you think Advanced Micro Devices (NASDAQ: AMD) is always behind Nvidia in the graphics card market while at the same time perpetually playing second fiddle to Intel within the computer processor arena, you're right. Namely, Advanced Micro Devices' hardware is a favorite among hardcore video gamers because it's affordable without sacrificing performance.
